Back
Marker Therapeutics Vs. Armata Pharmaceuticals Industry Stock Comparison
Sell
39
MRKR
Marker Therapeutics
Last Price:
3.64
Seasonality Move:
8.13%
Buy
87
ARMP
Armata Pharmaceuticals
Last Price:
2.76
Seasonality Move:
12.82%
Sell
39
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $3.72. The Score for MRKR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
87
Armata Pharmaceuticals (ARMP)
is a Buy
Is Armata Pharmaceuticals a Buy, Sell or Hold?
- The current Armata Pharmaceuticals [ARMP] share price is $2.75. The Score for ARMP is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- ARMP is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $3.72
The current trend is moderately bearish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARMP Stock Price Chart
What is Armata Pharmaceuticals's stock price today?
-
The Armata Pharmaceuticals share price today is $2.75
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARMP is experiencing buying pressure, which is a positive indicator for future bullish movement.
MRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 50.39 | Buy |
| Chaikin Money Flow: | 6992 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.12 - 4.28) | Buy |
| Bollinger Bands (100): | (2.95 - 4.81) | Sell |
ARMP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.02 | Buy |
| Relative Strength Index (14 RSI): | 69.07 | Buy |
| Chaikin Money Flow: | 25990 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.25 - 2.45) | Buy |
| Bollinger Bands (100): | (2.25 - 2.77) | Buy |
MRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Sell |
| 20-day SMA: | 3.94 | Sell |
| 50-day SMA: | 3.26 | Buy |
| 200-day SMA: | 4.04 | Sell |
| 8-day EMA: | 3.9 | Sell |
| 20-day EMA: | 3.79 | Sell |
| 50-day EMA: | 3.61 | Buy |
| 200-day EMA: | 3.87 | Sell |
ARMP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.35 | Buy |
| 20-day SMA: | 2.35 | Buy |
| 50-day SMA: | 2.33 | Buy |
| 200-day SMA: | 2.85 | Sell |
| 8-day EMA: | 2.39 | Buy |
| 20-day EMA: | 2.35 | Buy |
| 50-day EMA: | 2.38 | Buy |
| 200-day EMA: | 2.62 | Buy |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Armata Pharmaceuticals Earnings Growth & ARMP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.52 per share.
Marker Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Armata Pharmaceuticals Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||